262 related articles for article (PubMed ID: 34122442)
1. Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Vidovic D; Simms GA; Pasternak S; Walsh M; Peltekian K; Stein J; Helyer LK; Giacomantonio CA
Front Immunol; 2021; 12():678028. PubMed ID: 34122442
[TBL] [Abstract][Full Text] [Related]
2. Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients.
Ulrich C; Bichel J; Euvrard S; Guidi B; Proby CM; van de Kerkhof PC; Amerio P; Rønnevig J; Slade HB; Stockfleth E
Br J Dermatol; 2007 Dec; 157 Suppl 2(Suppl 2):25-31. PubMed ID: 18067628
[TBL] [Abstract][Full Text] [Related]
3. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
[TBL] [Abstract][Full Text] [Related]
4. Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
Hasan ZU; Ahmed I; Matin RN; Homer V; Lear JT; Ismail F; Whitmarsh T; Green AC; Thomson J; Milligan A; Hogan S; Van-de-Velde V; Mitchell-Worsford L; Kentley J; Gaunt C; Jefferson-Hulme Y; Bowden SJ; Gaunt P; Wheatley K; Proby CM; Harwood CA
Br J Dermatol; 2022 Sep; 187(3):324-337. PubMed ID: 34988975
[TBL] [Abstract][Full Text] [Related]
5. A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell Carcinoma.
Tsung I; Worden FP; Fontana RJ
Oncologist; 2021 Feb; 26(2):133-138. PubMed ID: 32969143
[TBL] [Abstract][Full Text] [Related]
6. Prompt response of advanced cutaneous squamous cell carcinoma to cemiplimab in a kidney transplant patient receiving treatment with everolimus.
Gambichler T; Hessam S; Lüttringhaus T; Boms S
Clin Exp Dermatol; 2022 Mar; 47(3):608-609. PubMed ID: 34767651
[TBL] [Abstract][Full Text] [Related]
7. The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients.
Metchnikoff C; Mully T; Singer JP; Golden JA; Arron ST
J Am Acad Dermatol; 2012 Nov; 67(5):829-35. PubMed ID: 22285618
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy.
Smith KJ; Germain M; Skelton H
Dermatol Surg; 2001 Jun; 27(6):561-4. PubMed ID: 11442593
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
[TBL] [Abstract][Full Text] [Related]
10. Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma.
Green DS; Bodman-Smith MD; Dalgleish AG; Fischer MD
Br J Dermatol; 2007 Feb; 156(2):337-45. PubMed ID: 17223875
[TBL] [Abstract][Full Text] [Related]
11. Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients.
Smith KJ; Hamza S; Skelton H
Dermatol Surg; 2004 Apr; 30(4 Pt 2):634-41. PubMed ID: 15061848
[TBL] [Abstract][Full Text] [Related]
12. Parotid metastases of cutaneous squamous cell carcinoma in renal transplant recipients: Case series and literature review.
Mokos M; Bašić-Jukić N
Dermatol Ther; 2021 May; 34(3):e14907. PubMed ID: 33619803
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma.
Santana AL; Felsen D; Carucci JA
Dermatol Clin; 2017 Jan; 35(1):73-84. PubMed ID: 27890239
[TBL] [Abstract][Full Text] [Related]
14. 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series.
Shi VY; Tran K; Patel F; Leventhal J; Konia T; Fung MA; Wilken R; Garcia MS; Fitzmaurice SD; Joo J; Monjazeb AM; Burrall BA; King B; Martinez S; Christensen SD; Maverakis E
J Am Acad Dermatol; 2015 Oct; 73(4):645-54. PubMed ID: 26259990
[TBL] [Abstract][Full Text] [Related]
15. Rates of Second Tumor, Metastasis, and Death From Cutaneous Squamous Cell Carcinoma in Patients With and Without Transplant-Associated Immunosuppression.
Gjersvik P; Falk RS; Roscher I; Rizvi SMH; Mjøen G; Gude E; Leuckfeld I; Boberg KM; Veierød MB; Robsahm TE
JAMA Dermatol; 2023 Sep; 159(9):923-929. PubMed ID: 37466985
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of high-grade vulval intra-epithelial neoplasia with imiquimod 5% in a renal transplant recipient.
Khatun A; Lotery H; Sundaram S
Int J STD AIDS; 2019 Feb; 30(2):198-200. PubMed ID: 30284955
[TBL] [Abstract][Full Text] [Related]
17. Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients.
Strobel SB; Safferling K; Lahrmann B; Hoffmann JH; Enk AH; Hadaschik EN; Grabe N; Lonsdorf AS
Br J Dermatol; 2018 Aug; 179(2):405-412. PubMed ID: 29479687
[TBL] [Abstract][Full Text] [Related]
18. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
19. Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer.
Peters FS; Peeters AMA; Mandaviya PR; van Meurs JBJ; Hofland LJ; van de Wetering J; Betjes MGH; Baan CC; Boer K
Clin Epigenetics; 2018; 10():81. PubMed ID: 29946375
[TBL] [Abstract][Full Text] [Related]
20. Treatment of metastatic cutaneous squamous cell carcinoma in a solid organ transplant recipient with programmed death-1 checkpoint inhibitor therapy.
O'Connell KA; Schmults CD
J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():45-48. PubMed ID: 34855241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
